121082-99-3 Usage
General Description
1-(3,4,5-Trimethoxy-phenyl)-ethylamine, also known as TMA-6, is a chemical compound that belongs to the class of phenethylamines. It is structurally similar to the hallucinogenic drug mescaline and has been found to have hallucinogenic effects in humans. TMA-6 is known to bind to the serotonin receptor, and its effects are thought to be mediated through this interaction. It is a psychoactive substance that has been studied for its potential therapeutic effects, particularly in the treatment of depression and anxiety. However, its use is illegal in many countries and its safety and efficacy for medical use have not been established.
Check Digit Verification of cas no
The CAS Registry Mumber 121082-99-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,0,8 and 2 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 121082-99:
(8*1)+(7*2)+(6*1)+(5*0)+(4*8)+(3*2)+(2*9)+(1*9)=93
93 % 10 = 3
So 121082-99-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H17NO3/c1-7(12)8-5-9(13-2)11(15-4)10(6-8)14-3/h5-7H,12H2,1-4H3/p+1/t7-/m1/s1
121082-99-3Relevant articles and documents
APPLICATIONS OF N6-SUBSTITUTED ADENOSINE DERIVATIVE AND N6-SUBSTITUTED ADENINE DERIVATIVE TO CALMING, HYPNOSES, CONVULSION RESISTANCE, EPILEPTIC RESISTANCE, PARKINSON DISEASE RESISTANCE, AND DEMENTIA PREVENTION AND TREATMENT
-
Paragraph 0144, (2018/10/27)
PROBLEM TO BE SOLVED: To prepare analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. SOLUTION: The present invention relates to an N6-substituted adenosine derivative and an N6-substituted adenine derivative selected from the group consisting of specific compounds. The present invention also relates to a pharmaceutical composition at least comprising a therapeutically effective amount of the compounds and a pharmaceutically acceptable carrier. The invention further relates to the compounds used in preparation of analgesics, hypnotic agents, anticonvulsant agents, antiepileptics, antiparkinson drugs, dementia prophylactics, and health care food. COPYRIGHT: (C)2016,JPO&INPIT